Annual Report

Overview

The report describes Joincare's 2022 performance across a consolidated pharmaceutical group, including RMB17,142,753,068.82 in total revenues and continued R&D expansion. It highlights six products approved for launch and progress in inhalation formulations, vaccines and complex formulations. Environmental actions included carbon-emission reductions of 2,171 ton and a stated ambition to achieve carbon neutrality by 2055. The company also reports 14,116 employees and extensive public-welfare activity.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 7 April 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services